http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102631345-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
| filingDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102631345-B |
| titleOfInvention | Pharmaceutical composition and its application for reversing tumor cellular drug resistance |
| abstract | The present invention relates to a kind of pharmaceutical compositions and its application for reversing tumor cellular drug resistance.Specifically, the invention discloses a kind of isocorydine (Isocorydin, ICD) or the new applications of its pharmaceutically acceptable salt, are used to prepare the pharmaceutical composition for the treatment of tumour.Tumour cell can be improved to the sensibility of anti-tumor drug in described pharmaceutical composition, or reduces tumour cell to the drug resistance of anti-tumor drug. |
| priorityDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.